SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Bellerophon Therapeutics Q3 EPS $(0.06) Up From $(0.1) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.1) per share from the same period last year.

Benzinga · -

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.1) per share from the same period last year.